Colposcopy
Home ] GynaeOnc Centre ] Submit MDT case ] Protocols ] Students ] Staff ] Consultants ] Links ]

Top

 

View Word document version of this page

 

Colposcopy Protocol

 

Responsible for policy - Paul Carter

Last reviewed - 22/3/2005

Last date page electronically updated - 11/09/2005

Next review - 1/4/2006

 

 

COLPOSCOPY CLINIC PROTOCOL

It should be noted that this protocol is a guide to treatment and not policy set in stone.

 

General protocol for the colposcopy service

Management of borderline and mildly dyskaryotic smears

(I) Complete colposcopy & absence of visible abnormality

(II) Complete colposcopy & visible abnormality

(III) Incomplete colposcopy & visible abnormality

(IV) Incomplete colposcopy & no visible abnormality

Management of moderately and severely dyskaryotic smears

(I) Complete colposcopy & absence of visible abnormality

(II) Complete colposcopy & visible abnormality

(III) Incomplete colposcopy & visible abnormality

(IV) Incomplete colposcopy & no visible abnormality

Management of invasive smears

Management of glandular abnoramlities

Inadequate smears

Persistent borderline/Inflammatory smears

(I) Normal colposcopy

(II) Abnormal colposcopy

Treatment

(I) Under Local Anaesthesia in Colposcopy Clinic

(II) Under general Anaesthesia as Day Case or In-patient

(III) Pre-treatment Counselling

Follow-up after treatment

(I) Complete excision of CIN I

(II) Complete excision of CIN II & III

(III) Criteria for follow-up in colposcopy clinic 

Abnormalities during follow-up after treatment of CIN

Dyskaryosis following previous treatment

Follow-up after hysterectomy

Management of the abnormal smear during pregnancy

 

 

GENERAL PROTOCOLS FOR THE COLPOSCOPY SERVICE

Top of page

 

 

MANAGEMENT OF BORDERLINE/MILDLY DYSKARYOTIC SMEARS

 

(I) Complete colposcopy & absence of visible abnormality

(a) - Repeat smear & review 9/12 if result is no worse than mild dyskaryosis.

(b) - Inspect vagina for possible origin of dyskaryotic cells.

(c) - If repeat smear normal & follow-up colposcopy & smear normal at 9/12 then refer to GP for repeat smear after 6,12 and 24 months and then return to normal screening.

(d) - If colposcopy normal at 9/12 but mild dyskaryosis persists - give patient options;

i) continue colposcopy review every 9/12 until 2 consecutive normal smears or dyskaryosis deteriorates and treatment is needed.

ii) treatment (esp if family complete/post-menopause/suspected poor compliance).

Top of page

 

 

(II) Complete colposcopy & visible abnormality

(a) -Take biopsy/biopsies and if CIN I confirmed - review 9/12.

(b) - If lesion persists give patient options;

i) continue 9/12 colposcopy review until lesion resolves and two consecutive smears are normal.

ii) lesion remains unchanged & patient requests treatment.

(c) - lesion deteriorates cytologically/histologically and treatment is required.

(d) - If initial biopsy confirms CIN II/III - offer treatment.

Top of page

 

 

(III) Incomplete colposcopy & visible abnormality

(a) - As for (II) but brush smears necessary in addition to spatula/broom.

(b) -Low threshold for treatment if cytological/histological/colposcopic abnormality persists with incomplete colposcopic assessments.

Top of page

 

 

(IV) Incomplete colposcopy & no visible abnormality

(a) - Six monthly colposcopy with spatula & brush smears until 2 normal consecutive smears or dyskaryosis persists/deteriorates and treatment is recommended.

(b) - Recommend treatment if dyskaryosis persists/deteriorates.

Top of page

 

 

MANAGEMENT OF MODERATELY/SEVERELY DYSKARYOTIC SMEARS

 

(I) Complete colposcopy & absence of visible abnormality

(a) - Repeat smear & review 6/12 if no worse than mild dyskaryosis & ask cytologist to review referral slide. If repeat smear worse than mild change, offer treatment.

(b) - If colposcopy normal at 6/12, repeat smear & consider 4 quadrant biopsy and review every 6/12 if no worse than mild dyskaryosis or CIN I.

(c) - If colposcopy normal at 1 year but mild dyskaryosis persists - give patient options;

i) Observation - continue colposcopy review every 6/12 until 2 consecutive normal smears or dyskaryosis deteriorates and treatment is needed.

ii) treatment (esp if family complete/post-menopause/poor compliance).

(d) - If colposcopy & smear normal at 1 year repeat after further 6/12 and then refer back to GP, if normal, for repeat smear after 6/12 and then annually if normal.

(e) - Remember to inspect the vagina as a possible source of dyskaryotic cells.

 Top of page

 

 

(II) Complete colposcopy & visible abnormality

(a) - If lesion consistent with cytological diagnosis offer treatment.

(b) - If lesion not consistent with cytology, repeat smear & take biopsy/biopsies and if no worse than mild dyskaryosis/CIN I, review 6/12. If worse offer treatment.

(c) - If lesion persists at 6/12 check, give patient options;

i) continue 6/12 review until lesion resolves and next two smears are normal.

ii) lesion remains unchanged & patient requests treatment.

iii) lesion deteriorates cytologically/histologically and treatment is required.

(d) - If biopsy confirms CIN II/III - offer treatment.

Top of page

 

 

(III) Incomplete colposcopy & visible abnormality

(a) - Offer treatment.

Top of page

 

 

(IV) Incomplete colposcopy & no visible abnormality

(a) - Offer treatment.

Top of page

 

 

MANAGEMENT OF INVASIVE SMEARS

Top of page

 

 

MANAGEMENT OF GLANDULAR ABNORMALITIES

Top of page

 

 

INADEQUATE SMEARS

Top of page

 

 

PERSISTENT BORDERLINE/INFLAMMATORY SMEARS

 

(I) Normal colposcopy

(a) Repeat colposcopy on 6 monthly basis but if a normal smear is not achieved consider 4 quadrant biopsy/LLETZ.

 

(b) If colposcopy is incomplete - have low threshold for LLETZ.

(II) Abnormal colposcopy

Take biopsy/biopsies and manage accordingly (regular review/LLETZ) until 2 consecutive normal smears are obtained.

 

Top of page

 

 

TREATMENT

(I) Under Local Anaesthesia in Colposcopy Clinic

a) high grade abnormality with corresponding cytological appearance

b) biopsy proven high grade CIN

c) biopsy proven low grade lesion if requested by patient

d) persistent low grade change

e) glandular abnormality

Top of page

 

 

(II) Under general Anaesthesia as Day Case or In-patient

a) poor toleration of colposcopic examination

b) restricted access

c) large lesion

d) patient request for G.A.

e) pregnancy

f) other pathology requiring a procedure under G.A.

Top of page

 

 

(III) Pre-treatment Counselling

a) written information sent in advance of the clinic visit

b) full explanation of procedure & post treatment expectations

c) if IUCD in situ explanation of  removal and replacement

d) appropriate advice if IUCD to be removed and not replaced

e) advice on pelvic rest

f) possible complications (check on peanut allergy)

g) communication of results in writing

h) plan for follow-up

i) verbal consent sufficient for L.A. procedure but written consent for G.A.

Top of page

 

 

FOLLOW-UP AFTER TREATMENT

Many colposcopic assessments will be incomplete, thus emphasising the importance of satisfactory cytological surveillance and in particular, adequate sampling of the endo-cervix with a brush and using counter-traction with a tenaculum if necessary .

 

(I) Complete excision if CIN I

(II) Complete excision of CIN II & III

(III) Criteria for follow-up in colposcopy clinic

Top of page

 

 

ABNORMALITIES DURING FOLLOW-UP AFTER TREATMENT OF  CIN

Top of page

 

 

DYSKARYOSIS FOLLOWING PREVIOUS TREATMENT

 

Colposcopic assessment is required with biopsy of any visible lesion. If no lesion seen then repeat cytology if colposcopy is complete If colposcopy is incomplete then have low threshold for repeat cone biopsy if dyskaryosis is moderate or severe, or obtain adequate endocervical cytology  if dyskaryosis is mild. If colposcopy remains incomplete and mild dyskaryosis persists then offer further treatment.

 

Top of page

 

 

FOLLOW-UP AFTER HYSTERECTOMY

Top of page

 

 

MANAGEMENT OF THE ABNORMAL SMEAR DURING PREGNANCY

1. Referral criteria should not differ in pregnant patients.

2. Patients to be seen within 4 weeks of referral

3. Patients with abnormal cytology and PV bleeding to be seen within 2 weeks.

4. Full colposcopic assessment with repeat cytology using spatula only (brush may cause rupture of membranes)

5. The main priority is to exclude invasive disease. This requires punch biopsies from the most abnormal looking areas.

6. LLETZ is not indicated during pregnancy due to the high chance of miscarriage

7. If invasive disease is excluded, repeat colposcopic assessments should be made at 12 weekly intervals up to 36 weeks gestation. The cytology should be repeated and further biopsies taken if necessary.

8. Following delivery, repeat colposcopy and cytology or treatment (LLETZ) should be performed after 3 months.

9. Diagnosis of invasive disease during pregnancy requires immediate referral to the Consultant Gynaecological Oncologist.

Top of page

 

Links

www.colposcopy.co.uk

www.colposcopyuk.co.uk

Home
Up
Services
Surgery
Med Oncol
Clin Oncol
Radiology
Pathology
Palliative Care
Cancer Types
Colposcopy